- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 872
Ola takes extra series J fare
On-demand ride platform Ola has added $15.3m to a round that now totals about $160m, though none of its corporate investors have so far contributed.
Feb 7, 2019Healthy.io takes home $18m
Samsung Next has taken part in a series B round that will fund the roll out of Healthy.io's home urinalysis analyser system in the UK and expansion in the US.
Feb 7, 2019Vinli makes tracks with Eon-backed series B
The automotive data platform developer, which counts Samsung, Cox Enterprises and Continental as shareholders, has secured $13.5m in its series B round.
Feb 7, 2019Mobidiag mobilises Autobio investment
The molecular diagnostics equipment provider has completed a $11.3m investment from China-based Autobio Diagnostics that was announced in December.
Feb 7, 2019C-Capture catches $4.6m
IP Group returned to join corporates BP and Drax for the Leeds CO2 capture spinout’s latest round, taking its total investment in the company to $2.2m since 2009.
Feb 7, 2019Bolt hits series B with $54m
Nan Fung Life Sciences and Novo have taken part in a series B round for Stanford's immuno-oncology drug developer Bolt Biotherapeutics.
Feb 6, 2019Reddit readies $300m series D round
Tencent is in talks to invest $150m in Reddit, an online social platform backed by Condé Nast, as part of a series D round that could reach $300m and value it at $3bn.
Feb 6, 2019Zomato increases latest serving to $250m
Glade Brook Capital has invested $39.7m in food listings and ordering platform Zomato, adding to $210m from Ant Financial in October.
Feb 6, 2019Raisin puts $114m in its account
PayPal followed an investment in 2017 by participating in a series D round for the cross-border savings platform that will fund geographic expansion.
Feb 6, 2019Bolt hits series B with $54m
Nan Fung Life Sciences and Novo have taken part in the immuno-oncology drug developer's series B round, which was led by Pivotal BioVenture Partners.
Feb 6, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


